

Although the brochure states that fragments of the baby's DNA can be detected in the mother's blood from the early stages of pregnancy, for the PaternitySafe test it is recommended that the blood sample be taken from the expectant mother at 10 weeks of gestation at the earliest .
It is appropriate for the gestational age to be confirmed by ultrasound or a doctor's assessment.


It does not require sampling from the amniotic fluid or placenta. Therefore, the environment in which the baby is located is not entered for the purpose of the test.
The test can be performed from the recommended gestational week onward, without waiting for the baby to be born.
The small amount of the baby's DNA in the mother's blood is examined using Next-Generation Sequencing and advanced bioinformatic methods.
The test's sensitivity and specificity are above 99%, so paternity results are reported with high reliability.

The alleged father cannot be excluded as the baby's biological father. When the genetic characteristics match, the result can be reported with a paternity probability of over 99.9% .
No genetic match is found, and it is concluded that the alleged father is not the biological father.
The laboratory analysis time is usually 15 working days.


The mother's blood contains DNA fragments belonging to both the mother and the baby. Knowing the mother's genetic characteristics helps to identify the baby's portion more accurately.
Therefore, the test is performed not only with the sample taken from the alleged father but together with the expectant mother's blood sample.

